NSE - Delayed Quote ? INR Orchid Pharma Limited (ORCHPHARMA.NS) Follow Compare 1,248.65 -64.30 (-4.90%) At close: 3:29 PM GMT+5:30 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Undiscovered Gems in India to Watch This September 2024 The Indian market has climbed 1.0% over the last week and is up 45% over the last 12 months, with earnings expected to grow by 17% per annum over the next few years. In this favorable environment, identifying stocks with strong growth potential and solid fundamentals can offer promising opportunities for investors. Simply Wall St. ? last month NETWEB.BO NETWEB.NS ORCHPHARMA.BO Undervalued Indian Stocks That May Be Trading Below Intrinsic Value In August 2024 The Indian market has climbed 1.6% over the last week and is up 43% over the past 12 months, with earnings forecast to grow by 17% annually. In such a robust environment, identifying undervalued stocks that may be trading below their intrinsic value can offer significant opportunities for investors seeking growth potential. Simply Wall St. ? 2 months ago BANDHANBNK.BO BANDHANBNK.NS ORCHPHARMA.BO Jai Balaji Industries And Two More Undiscovered Gems In India India's stock market has experienced a slight decline of 1.0% over the past week, yet it boasts an impressive annual growth of 44%, with earnings expected to grow by 16% annually. In this dynamic environment, identifying stocks like Jai Balaji Industries that have potential yet remain under the radar can offer intriguing opportunities for informed investors. Simply Wall St. ? 2 months ago NPST-SM.NS NPST.NS ORCHPHARMA.BO Exploring Undiscovered Gems In India For July 2024 The Indian stock market has experienced a notable trajectory, declining 1.3% over the past week but soaring 43% over the last year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that have not yet caught the attention of mainstream investors can offer unique opportunities for growth. Simply Wall St. ? 2 months ago JAIBALAJI.BO JAIBALAJI.NS NPST-SM.NS Exploring Undiscovered Gems In India July 2024 Amidst a backdrop of recent selloffs and heightened volatility in the Indian stock market, investors are navigating through a phase marked by valuation concerns and economic uncertainties. As the Sensex and Nifty 50 show signs of strain, exploring undiscovered gems could potentially offer unique opportunities in such turbulent times. In this context, understanding the resilience and growth potential of smaller companies becomes crucial, especially when broader market sentiments are mixed and... Simply Wall St. ? 2 months ago ETHOSLTD.BO ETHOSLTD.NS ORCHPHARMA.BO Exploring Undiscovered Gems In Indian Stocks July 2024 The Indian stock market has experienced a notable fluctuation recently, declining by 2.0% over the last week, yet showing an impressive annual increase of 43%. In this context, identifying stocks with potential for robust earnings growth, forecasted at 16% annually, becomes particularly compelling for investors looking to uncover less recognized opportunities in such a dynamic market. Simply Wall St. ? 2 months ago ETHOSLTD.BO ETHOSLTD.NS ORCHPHARMA.BO Exploring Three Undiscovered Gems In Indian Stocks July 2024 In the past year, the Indian stock market has shown remarkable resilience with a 43% increase, despite a recent 2.0% drop over the last week. In this context of robust annual earnings growth forecasted at 16%, identifying stocks that have not yet caught the attention of mainstream investors could offer unique opportunities for those looking to diversify their portfolios. Simply Wall St. ? 2 months ago ORCHPHARMA.BO ORCHPHARMA.NS -4.90% TECHNOE.BO Uncovering July 2024's Undiscovered Gems In India The Indian market has experienced a mix of dynamics recently, with a 1.5% decline over the last week contrasting sharply against a robust annual growth of 44%. In this context, identifying stocks that not only have strong fundamentals but also the potential for significant earnings growth becomes particularly compelling. Simply Wall St. ? 2 months ago NPST-SM.NS NPST.NS TECHNOE.BO Performance Overview Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX Return ORCHPHARMA.NS S&P BSE SENSEX YTD +75.25% +11.05% 1-Year +164.57% +22.67% 3-Year +196.52% +31.67%
